Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06706674
PHASE3

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

Sponsor: Intra-Cellular Therapies, Inc.

View on ClinicalTrials.gov

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) and confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL).

Official title: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

Key Details

Gender

All

Age Range

5 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

174

Start Date

2024-12-06

Completion Date

2027-04

Last Updated

2025-07-08

Healthy Volunteers

No

Interventions

DRUG

Lumateperone high dose

Lumateperone administered orally once daily

DRUG

Lumateperone low dose

Lumateperone administered orally once daily

DRUG

Placebo

Matching Placebo administered orally once daily

Locations (39)

Clinical Site

Little Rock, Arkansas, United States

Clinical Site

Imperial, California, United States

Clinical Site

Sacramento, California, United States

Clinical Site

Sherman Oaks, California, United States

Clinical Site

New Haven, Connecticut, United States

Clinical Site

Hialeah, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami, Florida, United States

Clinical Site

Miami Gardens, Florida, United States

Clinical Site

Miami Lakes, Florida, United States

Clinical Site

Orlando, Florida, United States

Clinical Site

Orlando, Florida, United States

Clinical Site

Pompano Beach, Florida, United States

Clinical Site

Atlanta, Georgia, United States

Clinical Site

Lawrenceville, Georgia, United States

Clinical Site

Naperville, Illinois, United States

Clinical Site

Evansville, Indiana, United States

Clinical Site

Indianapolis, Indiana, United States

Clinical Site

Boston, Massachusetts, United States

Clinical Site

Bloomfield Hills, Michigan, United States

Clinical Site

St Louis, Missouri, United States

Clinical Site

Lincoln, Nebraska, United States

Clinical Site

Orangeburg, New York, United States

Clinical Site

Staten Island, New York, United States

Clinical Site

The Bronx, New York, United States

Clinical Site

Kinston, North Carolina, United States

Clinical Site

Avon Lake, Ohio, United States

Clinical Site

Oklahoma City, Oklahoma, United States

Clinical Site

Charleston, South Carolina, United States

Clinical Site

Austin, Texas, United States

Clinical Site

Coppell, Texas, United States

Clinical Site

Dallas, Texas, United States

Clinical Site

Fort Worth, Texas, United States

Clinical Site

Houston, Texas, United States

Clinical Site

Richmond, Virginia, United States

Clinical Site

Everett, Washington, United States